Chipman Stroud is a Senior Clinical Scientist at Genentech since July 2017, focusing on product development in oncology, specifically the Tiragolumab Lung Program. Previously, Chipman served as a Senior Medical Science Liaison and a Medical Science Liaison in oncology, with responsibilities spanning multiple divisions including Lung and GU/Derm. Prior to Genentech, Chipman was the Clinical Pharmacist Practitioner and Director of the Symptom Management Service at The Brody School of Medicine at East Carolina University, where a pioneering ambulatory oncology practice was established. This role included managing chemotherapy-related toxicities, teaching within the Hem/Onc Fellowship Program, and working closely in multidisciplinary tumor boards. Chipman holds a Doctor of Pharmacy degree from The University of North Carolina at Chapel Hill.
This person is not in the org chart
This person is not in any teams
This person is not in any offices